Water Quality and Health

This project evaluated the current status of antimicrobial resistance (AMR) in Scotland’s waters and identified emerging monitoring approaches and potential technological solutions. The project involved a literature review and elicitation of expert opinion via the use of a questionnaire survey of academics, industry and regulatory stakeholders, and a follow-up workshop. Findings were synthesised into a policy briefing on “Technologies for monitoring and treatment of antimicrobial resistance in water” and a Policy Note on “Antimicrobial resistance in Scotland’s waters”.

Private small sewage systems, such as septic tanks, if not properly managed, can lead to a number of issues including pollution of the water environment and nuisance issues such as ponding and odour. These issues can have significant negative impacts on local communities and are difficult for these communities to address.

The prescription of pharmaceuticals is the most commonly used healthcare intervention and indisputably has an important role to play in human health. However, pharmaceuticals can have negative effects on the environment and living organisms. Firstly, pharmaceutical use significantly contributes to the healthcare sector’s carbon emissions. Secondly, pharmaceutical residues from human excretions and improper disposal of unused medicines can enter the water environment through wastewater and endanger aquatic life.

This study carried out by researchers at Glasgow Caledonian University (GCU), with the James Hutton Institute and the Environmental Research Institute (University of the Highlands and Islands) delivered the first national assessment of the emerging area of concern around pharmaceutical pollution of Scotland’s water environment, with an innovative Scottish partnership (One Health Breakthrough Partnership) using results to promote practical actions to reduce this globally recognised public health and environmental issue.

Living within a viral pandemic has brought home the importance of our relationship with microbes. Yet we are in the midst of another microbial risk that threatens to have a much larger impact on our lives. Microbes (bacteria, viruses, fungi or protists) that cause disease in humans, animals or plants are normally treated with antimicrobial drugs to control their numbers. Drug use has become routine since Alexander Fleming’s famous discovery of penicillin, in public health, veterinary practice and crop protection.